|
1
|
Condeelis J and Pollard JW: Macrophages:
Obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kolahdooz F, Jang SL, Corriveau A, Gotay
C, Johnston N and Sharma S: Knowledge, attitudes, and behaviours
towards cancer screening in indigenous populations: A systematic
review. Lancet Oncol. 15:e504–e516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amarilio R, Ramachandran S, Sabanay H and
Lev S: Differential regulation of endoplasmic reticulum structure
through VAP-Nir protein interaction. J Biol Chem. 280:5934–5944.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang CY, Lee YH, Leu SJ, Wang CY, Wei CP,
Hung KS, Pai MH, Tsai MD and Wu CH: CC-chemokine ligand
18/pulmonary activation-regulated chemokine expression in the CNS
with special reference to traumatic brain injuries and neoplastic
disorders. Neuroscience. 165:1233–1243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coussens LM, Tinkle CL, Hanahan D and Werb
Z: MMP-9 supplied by bone marrow-derived cells contributes to skin
carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate
pulmonary metastasis of mammary carcinomas by enhancing protumor
properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Yao Y, Gong C, Yu F, Su S, Chen J,
Liu B, Deng H, Wang F, Lin L, et al: CCL18 from tumor-associated
macrophages promotes breast cancer metastasis via PITPNM3. Cancer
Cell. 19:541–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marino AL, Evangelista AF, Vieira RA,
Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira
HC and Marques MM: MicroRNA expression as risk biomarker of breast
cancer metastasis: A pilot retrospective case-cohort study. BMC
Cancer. 14:7392014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim VN and Nam JW: Genomics of microRNA.
Trends Genet. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M and Campiglio
M: MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sochor M, Basova P, Pesta M, Dusikova P,
Bartos J, Burda P, Pospisil V and Stopka T: Oncogenic microRNAs:
miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early
breast cancer in serum. BMC Cancer. 14:4482014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mansueto G, Forzati F, Ferraro A, Pallante
P, Bianco M, Esposito F, Iaccarino A, Troncone G and Fusco A:
Identification of a new pathway for tumor progression:
MicroRNA-181b up-regulation and CBX7 down-regulation by HMGA1
protein. Genes Cancer. 1:210–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Wu C, Ju J and Jiang J: miR-181b as
a key regulator of the oncogenic process and its clinical
implications in cancer (Review). Biomed Rep. 2:7–11.
2014.PubMed/NCBI
|
|
18
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun X, Icli B, Wara AK, Belkin N, He S,
Kobzik L, Hunninghake GM and Vera MP: MICU Registry, Blackwell TS,
et al: MicroRNA-181b regulates NF-κB-mediated vascular
inflammation. J Clin Invest. 122:1973–1990. 2012.PubMed/NCBI
|
|
20
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P,
Zhao P, Fu Z and You Y: hsa-mir-181a and hsa-mir-181b function as
tumor suppressors in human glioma cells. Brain Res. 1236:185–193.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kroski E, Fiori ME, Barbieri O, Astigiano
S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U,
et al: miR181b is induced by the chemopreventive polyphenol
curcumin and inhibits breast cancer metastasis via down regulation
of the inflammatory cytokines CXCL-1 and −2. Mol Oncol. 8:581–595.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappab in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slaby O: MicroRNA-181 family predicts
response to concomitant chemoradiotherapy with temozolomide in
glioblastoma patients. Neoplasma. 57:264–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Liu H, Wang H and Sun Y:
Down-regulation of microRNA-181b is a potential prognostic marker
of non-small cell lung cancer. Pathol Res Pract. 209:490–494. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Visone R, Veronese A, Rassenti LZ, Balatti
V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ and Croce
CM: miR-181b is a biomarker of disease progression in chronic
lymphocytic leukemia. Blood. 118:3072–3079. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu RX, Liu RY, Wu CM, Zhao YS, Li Y, Yao
YQ and Xu YH: DNA damage-induced NF-κB activation in human
glioblastoma cells promotes miR-181 bexpression and cell
proliferation. Cell Physiol Biochem. 35:913–925. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zehavi L, Schayek H, Jacob-Hirsch J, Sidi
Y, Leibowitz-Amit R and Avni D: MiR-377 targets E2F3 and alters the
NF-κB signaling pathway through MAP3K7 in malignant melanoma. Mol
Cancer. 14:682015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barbie TU, Alexe G, Aref AR, Li S, Zhu Z,
Zhang X, Imamura Y, Thai TC, Huang Y, Bowden M, et al: Targeting an
IKBKE cytokine network impairs triple-negative breast cancer
growth. J Clin Invest. 124:5411–5423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Noma N, Simizu S, Kambayashi Y, Kabe Y,
Suematsu M and Umezawa K: Involvement of NF-κB-mediated expression
of galectin-3-binding protein in TNF-α-induced breast cancer cell
adhesion. Oncol Rep. 27:2080–2084. 2012.PubMed/NCBI
|
|
32
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer.
2004:71–78. 2004. View
Article : Google Scholar
|
|
34
|
Ma X, Buscaglia LE Becker, Barker JR and
Li Y: MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 3:159–166.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu W, Shan X, Wang T, Shu Y and Liu P:
miR-181b modulates multidrug resistance by targeting BCL2 in human
cancer cell lines. Int J Cancer. 127:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi L: hsa-mir-181a and hsa-mir-181b
function as tumor suppressors in human glioma cells. Brain Res.
1236:185–193. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Squadrito ML, Etzrodt M, De Palma M and
Pittet MJ: MicroRNA-mediated control of macrophages and its
implications for cancer. Trends Immunol. 34:350–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun X, Icli B, Wara AK, Belkin N, He S,
Kobzik L, Huninghake GM and Vera MP: MICU Registry, Blackwell TS,
et al: MicroRNA-181b regulates NF-κB-mediated vascular
inflammation. J Clin Invest. 122:1973–1990. 2012.PubMed/NCBI
|
|
39
|
Xie WD, Li MN, Xu NH, Lv Q, Huang N, He J
and Zhang Y: miR-181a regulates inflammation responses in monocytes
and macrophages. PLoS One. 8:e586392013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nariţa D, Seclaman E, Ursoniu S, Ilina R,
Cireap N and Anghel A: Expression of CCL18 and interleukin-6 in the
plasma of breast cancer patients as compared with benign tumor
patients and healthy controls. Rom J Morphol Embryol. 52:1261–1267.
2011.PubMed/NCBI
|
|
41
|
Zhang W, Shen X, Xie L, Chu M and Ma Y:
MicroRNA-181b regulates endotoxin tolerance by targeting IL-6 in
macrophage RAW264.7 cells. J Inflamm (Lond). 12:182015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jing H and Lee S: NF-κB in cellular
senescence and cancer treatment. Mol Cells. 37:189–195. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Erstad DJ and Cusack JC Jr: Targeting the
NF-κB pathway in cancer therapy. Surg Oncol Clin N Am. 22:705–746.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk
ML and Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN
and CYLD are part of the epigenetic switch linking inflammation to
cancer. Mol Cell. 39:493–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schetter AJ, Heegaard NH and Harris CC:
Inflammation and cancer: Interweaving microRNA, free radical,
cytokine and p53 pathways. Carcinogenesis. 31:37–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lin X, Chen L, Yao Y, Zhao R, Cui X, Chen
J, Hou K, Zhang M, Su F, Chen J and Song E: CCL18-mediated
down-regulation of miR98 and miR27b promotes breast cancer
metastasis. Oncotarget. 6:20485–20499. 2015. View Article : Google Scholar : PubMed/NCBI
|
